203 related articles for article (PubMed ID: 1285135)
1. Serotype specificity of vaccine-induced immunity to pertussis.
Preston NW; Carter EJ
Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R155-6. PubMed ID: 1285135
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
[TBL] [Abstract][Full Text] [Related]
3. Essential immunogens in human pertussis: the role of fimbriae.
Preston NW
Dev Biol Stand; 1985; 61():137-41. PubMed ID: 2872099
[TBL] [Abstract][Full Text] [Related]
4. Why do pertussis vaccines fail?
Cherry JD
Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
[No Abstract] [Full Text] [Related]
5. [Acellular pertussis vaccine].
Wiedermann G; Ambrosch F; Vanura H
Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children.
Lacombe K; Yam A; Simondon K; Pinchinat S; Simondon F
Vaccine; 2004 Dec; 23(5):623-8. PubMed ID: 15542182
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
[TBL] [Abstract][Full Text] [Related]
8. Bordetella pertussis serotype of clinical isolates in Sweden during 1970-1995 and influence of vaccine efficacy studies.
Tiru M; Askelöf P; Granström M; Hallander H
Dev Biol Stand; 1997; 89():239-45. PubMed ID: 9272356
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis serotypes in Canada.
Toma S; Lo H; Magus M
Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough.
Williamson P; Matthews R
FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026
[TBL] [Abstract][Full Text] [Related]
12. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
David S; van Furth R; Mooi FR
Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
[TBL] [Abstract][Full Text] [Related]
13. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
15. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
[TBL] [Abstract][Full Text] [Related]
16. [Immunologic findings in oral pertussis vaccination].
Kurz R; Mayr J; Höfler KH; Falk W; Rosanelli K
Padiatr Padol; 1986; 21(1):53-9. PubMed ID: 2870453
[TBL] [Abstract][Full Text] [Related]
17. Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.
Knowles K; Lorange M; Matthews RC; Preston NW
Can Commun Dis Rep; 1993 Nov; 19(21):182-3, 186-7. PubMed ID: 8298581
[No Abstract] [Full Text] [Related]
18. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
[TBL] [Abstract][Full Text] [Related]
19. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
20. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
